Publikationen, an denen er mitarbeitet Javier López Díaz (11)

2022

  1. Frailty and prognosis of older patients with chronic heart failure

    Revista Espanola de Cardiologia, Vol. 75, Núm. 12, pp. 1011-1019

2018

  1. An Easy Assessment of Frailty at Baseline Independently Predicts Prognosis in Very Elderly Patients With Acute Coronary Syndromes

    Journal of the American Medical Directors Association, Vol. 19, Núm. 4, pp. 296-303

  2. Global Geriatric Assessment and In-Hospital Bleeding Risk in Elderly Patients with Acute Coronary Syndromes: Insights from the LONGEVO-SCA Registry

    Thrombosis and Haemostasis, Vol. 118, Núm. 3, pp. 581-590

  3. Selection of the Best of 2017 in Heart Failure in Elderly Patients

    Revista Espanola de Cardiologia, Vol. 71, Núm. 2, pp. 120-121

2017

  1. Selección de lo mejor del año 2016 en valvulopatía aórtica e insuficiencia cardiaca en el paciente anciano

    Revista Espanola de Cardiologia, Vol. 70, Núm. 1, pp. 60-61

2016

  1. Comparison of 1-Year Outcome in Patients with Severe Aorta Stenosis Treated Conservatively or by Aortic Valve Replacement or by Percutaneous Transcatheter Aortic Valve Implantation (Data from a Multicenter Spanish Registry)

    American Journal of Cardiology, Vol. 118, Núm. 2, pp. 244-250

  2. Interatrial block and atrial arrhythmias in centenarians: Prevalence, associations, and clinical implications

    Heart Rhythm, Vol. 13, Núm. 3, pp. 645-651

  3. Sex-related differences in centenarians and their hearts

    Journal of the American Geriatrics Society

2015

  1. Centenarians and their hearts: A prospective registry with comprehensive geriatric assessment, electrocardiogram, echocardiography, and follow-up

    American Heart Journal, Vol. 169, Núm. 6, pp. 798-805.e2

2014

  1. Actualización en cardiopatía isquémica y cuidados críticos cardiológicos

    Revista Espanola de Cardiologia, Vol. 67, Núm. 2, pp. 120-126

2013

  1. Rationale and design of a randomized, double-blind, placebo controlled multicenter trial to study efficacy, security, and long term effects of intermittent repeated levosimendan administration in patients with advanced heart failure: LAICA study

    Cardiovascular Drugs and Therapy, Vol. 27, Núm. 6, pp. 573-579